Core Points - The listing of Aomeisen (920080.BJ) on October 10 marks the 278th company on the Beijing Stock Exchange (BSE) and signifies a new phase in the exchange's development with the introduction of the new 920 securities code [1][6] - The transition to the 920 code is seen as a significant milestone, indicating the BSE's maturation and independence as a national securities exchange [6][7] - Companies listed on the BSE, particularly "little giant" enterprises, express optimism about the opportunities and responsibilities that come with the new code [8][10] Summary by Sections Listing and Market Development - Aomeisen's listing on October 10, 2023, is a notable event for the BSE, which has now adopted the 920 code for all listed companies, moving away from the previous New Third Board codes [1] - The BSE has seen significant growth since its establishment, with the number of listed companies increasing and the total market capitalization rising [2] Significance of the 920 Code - The unified 920 code is viewed as a "coming-of-age" moment for the BSE, enhancing market recognition and establishing a clearer identity for listed companies [6][7] - The new code is expected to improve market visibility and valuation logic for BSE companies, facilitating better price discovery and capital operations [7][9] Opportunities and Responsibilities - Companies like Jinbo Biological and Sanyuan Gene highlight the dual nature of the new code as both an opportunity for increased attention and a responsibility for enhanced performance and disclosure [8][10] - The expectation for improved liquidity and research coverage is seen as beneficial for the pricing efficiency of BSE-listed companies [9] Future Market Reforms - There is anticipation for further market reforms, including the introduction of ETF products to attract more capital and improve liquidity [12] - Companies express a desire for enhanced financing and merger capabilities to support growth and innovation within the BSE framework [13]